Literature DB >> 28616311

Neutrophils dominate the immune landscape of non-small cell lung cancer.

Cristina Teixidó1,2, Rafael Rosell3.   

Abstract

Entities:  

Year:  2017        PMID： 28616311      PMCID： PMC5465158          DOI： 10.21037/jtd.2017.04.55

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  6 in total

1.  The prognostic landscape of genes and infiltrating immune cells across human cancers.

Authors:  Andrew J Gentles; Aaron M Newman; Chih Long Liu; Scott V Bratman; Weiguo Feng; Dongkyoon Kim; Viswam S Nair; Yue Xu; Amanda Khuong; Chuong D Hoang; Maximilian Diehn; Robert B West; Sylvia K Plevritis; Ash A Alizadeh
Journal:  Nat Med       Date:  2015-07-20       Impact factor: 53.440

2.  Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.

Authors:  Marcin Imielinski; Alice H Berger; Peter S Hammerman; Bryan Hernandez; Trevor J Pugh; Eran Hodis; Jeonghee Cho; James Suh; Marzia Capelletti; Andrey Sivachenko; Carrie Sougnez; Daniel Auclair; Michael S Lawrence; Petar Stojanov; Kristian Cibulskis; Kyusam Choi; Luc de Waal; Tanaz Sharifnia; Angela Brooks; Heidi Greulich; Shantanu Banerji; Thomas Zander; Danila Seidel; Frauke Leenders; Sascha Ansén; Corinna Ludwig; Walburga Engel-Riedel; Erich Stoelben; Jürgen Wolf; Chandra Goparju; Kristin Thompson; Wendy Winckler; David Kwiatkowski; Bruce E Johnson; Pasi A Jänne; Vincent A Miller; William Pao; William D Travis; Harvey I Pass; Stacey B Gabriel; Eric S Lander; Roman K Thomas; Levi A Garraway; Gad Getz; Matthew Meyerson
Journal:  Cell       Date:  2012-09-14       Impact factor: 41.582

Review 3.  Targeting PD-1/PD-L1 in lung cancer: current perspectives.

Authors:  María González-Cao; Niki Karachaliou; Santiago Viteri; Daniela Morales-Espinosa; Cristina Teixidó; Jesús Sánchez Ruiz; Miquel Ángel Molina-Vila; Mariacarmela Santarpia; Rafael Rosell
Journal:  Lung Cancer (Auckl)       Date:  2015-07-31

4.  Neutrophils dominate the immune cell composition in non-small cell lung cancer.

Authors:  Julia Kargl; Stephanie E Busch; Grace H Y Yang; Kyoung-Hee Kim; Mark L Hanke; Heather E Metz; Jesse J Hubbard; Sylvia M Lee; David K Madtes; Martin W McIntosh; A McGarry Houghton
Journal:  Nat Commun       Date:  2017-02-01       Impact factor: 14.919

5.  Comprehensive genomic characterization of squamous cell lung cancers.

Authors: 
Journal:  Nature       Date:  2012-09-09       Impact factor: 49.962

6.  Comprehensive molecular profiling of lung adenocarcinoma.

Authors: 
Journal:  Nature       Date:  2014-07-09       Impact factor: 49.962
  6 in total
  4 in total

1.  Polymorphonuclear Neutrophils and Tumors: Friend or Foe?

Authors:  Izabela Szulc-Kielbik; Magdalena Klink
Journal:  Exp Suppl       Date:  2022

2.  IL-17C-mediated innate inflammation decreases the response to PD-1 blockade in a model of Kras-driven lung cancer.

Authors:  Felix Ritzmann; Christopher Jungnickel; Giovanna Vella; Andreas Kamyschnikow; Christian Herr; Dong Li; Michael M Menger; Adrian Angenendt; Markus Hoth; Annette Lis; Robert Bals; C Beisswenger
Journal:  Sci Rep       Date:  2019-07-17       Impact factor: 4.379

3.  Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Restructures the Immune Contexture to Improve Checkpoint Blockade Efficacy.

Authors:  Nancy D Ebelt; Edith Zuniga; Monica Marzagalli; Vic Zamloot; Bruce R Blazar; Ravi Salgia; Edwin R Manuel
Journal:  Biomedicines       Date:  2020-12-16

4.  Molecular and Immune Characteristics for Lung Adenocarcinoma Patients With ERLIN2 Overexpression.

Authors:  Yifei Liu; Pengfei Xie; Daishang Jiang; Jian Liu; Jianguo Zhang; Tingting Bian; Jiahai Shi
Journal:  Front Immunol       Date:  2020-12-07       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.